Assessing the strength of innovations in the treatment of depression

Pim Cuijpers*, Mathias Harrer, Toshi Furukawa

*Corresponding author for this work

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

Although treatments for depression are effective, many patients do not respond. Many new innovations are currently being developed, claiming to substantially improve outcomes. We propose a new method to assess the strength of these innovations. Based on response rates of current treatments, we can estimate how many treatments are needed in total to realise response in >99% of patients if they were to be offered another treatment when the previous one did not work. Using a basic model as a benchmark, we can show that none of the current innovations likely represents a 'silver bullet' that will dramatically change the outcomes. Improvement of mental healthcare for depression needs to be done by multiple, incremental innovations. Only together can these innovations substantially improve outcomes.

Original languageEnglish
Pages (from-to)810-813
Number of pages4
JournalBritish Journal of Psychiatry
Volume227
Issue number5
Early online date21 May 2025
DOIs
Publication statusPublished - Nov 2025

Bibliographical note

Publisher Copyright:
© The Author(s), 2025. Published by Cambridge University Press on behalf of Royal College of Psychiatrists.

Keywords

  • Depression
  • innovation
  • major depressive disorder
  • psychotherapy and pharmacotherapy
  • treatment

Cite this